GlassScriptPhysician profile
Tyler Floyd
NPI 1770088965
$750.98
in general payments reported to CMS, 2019-2025
12 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $152 · 2021: $26.87 · 2023: $46.48 · 2024: $13.38 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $164.73 | 2025 | Hawkone, Inceptiv, Intellis Adaptivestim |
| Medshape, INC. | $147.53 | 2025 | Dynanail |
| Stryker Corporation | $111.93 | 2019 | |
| Integra Lifesciences Corporation | $100.00 | 2020 | |
| Smith+Nephew, INC. | $50.31 | 2020-2021 | |
| Trilliant Surgical LLC. | $46.48 | 2023 | Minimally Invasive Bunion Plate, Left |
| Reel Surgical, INC. | $31.37 | 2025 | |
| Wright Medical Technology, INC. | $28.06 | 2020 | |
| Organogenesis INC. | $23.13 | 2025 | Puraply Wound Matrix |
| Djo, LLC | $21.80 | 2019 | |
| Averitas Pharma INC. | $13.38 | 2024 | Qutenza |
| Merck Sharp & Dohme LLC | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.